precisionmedicineonline9h
Immuneering Partners with Regeneron to Study Combined MEK, PD-1 Inhibitor Therapy in Solid Tumors
NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...
voxelmatters20h
Vast’s Haven-1 has passed primary structure qualification proof test
Vast's bold ambition: developing Haven-1, the first commercial space station. Learn about their successful primary structure qualification proof test.
SpaceNews1d
Vast begins Haven-1 testing and reschedules its launch
Vast has started testing a qualification model of its first commercial space station but has pushed back the launch of that ...
Mens Fitness on MSN3d
Want a Bigger Pecs? Exercise Scientist Shares the Perfect Bench Workout
The exercise scientist recently shared a video with his tops tips for maximizing chest gains—especially for those who have ...